229 related articles for article (PubMed ID: 16356193)
1. B lymphocyte stimulator (BLyS) isoforms in systemic lupus erythematosus: disease activity correlates better with blood leukocyte BLyS mRNA levels than with plasma BLyS protein levels.
Collins CE; Gavin AL; Migone TS; Hilbert DM; Nemazee D; Stohl W
Arthritis Res Ther; 2006; 8(1):R6. PubMed ID: 16356193
[TBL] [Abstract][Full Text] [Related]
2. B lymphocyte stimulator expression in pediatric systemic lupus erythematosus and juvenile idiopathic arthritis patients.
Hong SD; Reiff A; Yang HT; Migone TS; Ward CD; Marzan K; Shaham B; Phei WC; Garza J; Bernstein B; Stohl W
Arthritis Rheum; 2009 Nov; 60(11):3400-9. PubMed ID: 19877053
[TBL] [Abstract][Full Text] [Related]
3. B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: longitudinal observations.
Stohl W; Metyas S; Tan SM; Cheema GS; Oamar B; Xu D; Roschke V; Wu Y; Baker KP; Hilbert DM
Arthritis Rheum; 2003 Dec; 48(12):3475-86. PubMed ID: 14673998
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of tumour necrosis factor family members a proliferation-inducing ligand (APRIL) and B lymphocyte stimulator (BLyS) are inversely correlated in systemic lupus erythematosus.
Morel J; Roubille C; Planelles L; Rocha C; Fernandez L; Lukas C; Hahne M; Combe B
Ann Rheum Dis; 2009 Jun; 68(6):997-1002. PubMed ID: 18676986
[TBL] [Abstract][Full Text] [Related]
5. Association of plasma B lymphocyte stimulator levels and disease activity in systemic lupus erythematosus.
Petri M; Stohl W; Chatham W; McCune WJ; Chevrier M; Ryel J; Recta V; Zhong J; Freimuth W
Arthritis Rheum; 2008 Aug; 58(8):2453-9. PubMed ID: 18668552
[TBL] [Abstract][Full Text] [Related]
6. B cell depletion therapy in systemic lupus erythematosus: relationships among serum B lymphocyte stimulator levels, autoantibody profile and clinical response.
Cambridge G; Isenberg DA; Edwards JC; Leandro MJ; Migone TS; Teodorescu M; Stohl W
Ann Rheum Dis; 2008 Jul; 67(7):1011-6. PubMed ID: 17962238
[TBL] [Abstract][Full Text] [Related]
7. Elevated B lymphocyte stimulator levels are associated with increased damage in an Irish systemic lupus erythematosus cohort.
McCarthy EM; Lee RZ; Ní Gabhann J; Smith S; Cunnane G; Doran MF; Howard D; O'Connell P; Kearns G; Jefferies CA
Rheumatology (Oxford); 2013 Jul; 52(7):1279-84. PubMed ID: 23479724
[TBL] [Abstract][Full Text] [Related]
8. B lymphocyte stimulator expression in patients with rheumatoid arthritis treated with tumour necrosis factor alpha antagonists: differential effects between good and poor clinical responders.
La DT; Collins CE; Yang HT; Migone TS; Stohl W
Ann Rheum Dis; 2008 Aug; 67(8):1132-8. PubMed ID: 17967830
[TBL] [Abstract][Full Text] [Related]
9. B lymphocyte stimulator levels in systemic lupus erythematosus: higher circulating levels in African American patients and increased production after influenza vaccination in patients with low baseline levels.
Ritterhouse LL; Crowe SR; Niewold TB; Merrill JT; Roberts VC; Dedeke AB; Neas BR; Thompson LF; Guthridge JM; James JA
Arthritis Rheum; 2011 Dec; 63(12):3931-41. PubMed ID: 22127709
[TBL] [Abstract][Full Text] [Related]
10. Elevated BLyS levels in patients with systemic lupus erythematosus: Associated factors and responses to belimumab.
Roth DA; Thompson A; Tang Y; Hammer AE; Molta CT; Gordon D
Lupus; 2016 Apr; 25(4):346-54. PubMed ID: 26385220
[TBL] [Abstract][Full Text] [Related]
11. Interferon-α-induced B-lymphocyte stimulator expression and mobilization in healthy and systemic lupus erthymatosus monocytes.
López P; Scheel-Toellner D; Rodríguez-Carrio J; Caminal-Montero L; Gordon C; Suárez A
Rheumatology (Oxford); 2014 Dec; 53(12):2249-58. PubMed ID: 24942493
[TBL] [Abstract][Full Text] [Related]
12. Correlation of the expression levels of BLyS and its receptors mRNA in patients with systemic lupus erythematosus.
Ju S; Zhang D; Wang Y; Ni H; Kong X; Zhong R
Clin Biochem; 2006 Dec; 39(12):1131-7. PubMed ID: 17069785
[TBL] [Abstract][Full Text] [Related]
13. B-lymphocyte activating factor in systemic lupus erythematosus and rheumatoid arthritis in relation to autoantibody levels, disease measures and time.
Becker-Merok A; Nikolaisen C; Nossent HC
Lupus; 2006; 15(9):570-6. PubMed ID: 17080911
[TBL] [Abstract][Full Text] [Related]
14. Inverse association between circulating APRIL levels and serological and clinical disease activity in patients with systemic lupus erythematosus.
Stohl W; Metyas S; Tan SM; Cheema GS; Oamar B; Roschke V; Wu Y; Baker KP; Hilbert DM
Ann Rheum Dis; 2004 Sep; 63(9):1096-103. PubMed ID: 15308519
[TBL] [Abstract][Full Text] [Related]
15. The role of baseline BLyS levels and type 1 interferon-inducible gene signature status in determining belimumab response in systemic lupus erythematosus: a post hoc meta-analysis.
Wilkinson C; Henderson RB; Jones-Leone AR; Flint SM; Lennon M; Levy RA; Ji B; Bass DL; Roth D
Arthritis Res Ther; 2020 May; 22(1):102. PubMed ID: 32366280
[TBL] [Abstract][Full Text] [Related]
16. BLyS levels in sera of patients with systemic lupus erythematosus: clinical and serological correlation.
Elbirt D; Asher I; Mahlab-Guri K; Bezalel-Rosenberg S; Edelstein V; Sthoeger Z
Isr Med Assoc J; 2014 Aug; 16(8):491-6. PubMed ID: 25269340
[TBL] [Abstract][Full Text] [Related]
17. Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases.
Cheema GS; Roschke V; Hilbert DM; Stohl W
Arthritis Rheum; 2001 Jun; 44(6):1313-9. PubMed ID: 11407690
[TBL] [Abstract][Full Text] [Related]
18. Analysis on the association of human BLYS (BAFF, TNFSF13B) polymorphisms with systemic lupus erythematosus and rheumatoid arthritis.
Kawasaki A; Tsuchiya N; Fukazawa T; Hashimoto H; Tokunaga K
Genes Immun; 2002 Nov; 3(7):424-9. PubMed ID: 12424625
[TBL] [Abstract][Full Text] [Related]
19. Preliminary clinical measurement of the expression of B-cell activating factor in Chinese systemic lupus erythematosus patients.
Lin Z; Dan-Rong Y; Xiao-Qing T; Hao W; Hong-Lian G; Xian-Tao K; Ren-Qian Z; Jiyu L
J Clin Lab Anal; 2007; 21(3):183-7. PubMed ID: 17506477
[TBL] [Abstract][Full Text] [Related]
20. The effect of BLyS on the activity of peripheral B lymphocytes mediated by BLyS receptors in patients with systemic lupus erythematosus.
Cheng Y; Yan S; Zhao W; Huang Q; Lian L; Wei W
Scand J Clin Lab Invest; 2013 Mar; 73(2):141-7. PubMed ID: 23336587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]